Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.
Identificadores
Identificadores
Data de publicación
2011Título da revista
PHARMACOGENOMICS
Tipo de contido
Artigo